D ilated cardiomyopathy is a disease of idiopathic origin characterized by reduced global left ventricular systolic function. Adjusted prevalence rates range from 4.4 per 100 000 for women to 11 per 100 000 for men.' Case fatality rates approach 30% at 3 years and 60% at 5 years after diagnosis.2 Whereas the treatment of dilated cardiomyopathy is largely empiric, important advances in medical (angiotensin-converting enzyme inhibitors, new inotropic drugs) and surgical therapy (heart transplantation) have occurred.
Besides diagnostic information, the comprehensive evaluation of patients with dilated cardiomyopathy includes an assessment of prognosis. The conventionally used prognostic variable has been left ventricular ejection fraction. However, as repeatedly demonstrated, patients with dilated cardiomyopathy and ejection fractions in the midrange (20% to 30%) may have a highly variable clinical course, and clinicians often face uncertainty in assessing the prognosis of a patient.
with an ejection fraction <0.25 and deceleration time <130 milliseconds had a 2-year survival of only 35%. The subgroup with ejection fraction <0. 25 and deceleration time >130 milliseconds had an intermediate 2-year survival of 72%, whereas patients with an ejection fraction .0.25 had 2-year survivals 295% regardless of deceleration time. In multivariate analysis, ejection fraction and systolic blood pressure were independently predictive of subsequent mortality. Mitral deceleration time was significant in univariate analysis.
Conclusions In patients with the clinical diagnosis of dilated cardiomyopathy, markers of diastolic dysfunction correlated strongly with congestive symptoms, whereas variables of systolic function were the strongest predictors of survival. Consideration of both ejection fraction and deceleration time allowed identification of subgroups with divergent long-term A wide range of diastolic transmitral flow velocity patterns exists in various cardiac disease states, and recent clinical and laboratory work has begun to shed light on the hemodynamic significance and prognostic implications of transmitral flow velocity profiles. [3] [4] [5] However, little information is available about Doppler echocardiographic hemodynamics and their relation to the pathophysiology and long-term outcomes of dilated cardiomyopathy.
The purpose of our study was to critically evaluate various clinical and echocardiographic variables among patients with the clinical diagnosis of dilated cardiomyopathy who underwent comprehensive echocardiographic examination at the Mayo Clinic Echocardiography Laboratory from 1986 to 1990. Follow-up data were obtained through July 1, 1991 . We hypothesized that left ventricular ejection fraction would incompletely characterize hemodynamics and prognosis in this patient population and that diastolic Doppler echocardiographic variables would add significantly to both of these aspects.
Methods

Research Design
The study was a retrospective cohort analysis that used the resources of the Mayo Clinic Echocardiography Laboratory and the Mayo Clinic medical records. All aspects of the study were subject to review by the Mayo Institutional Review Board; approval was given August 5, 1991.
Subjects
By using the Mayo Echocardiography Laboratory database (for the years 1986 to 1990), we identified all patients with the diagnosis of dilated cardiomyopathy (n=686). Of these 686 patients, 442 had complete two-dimensional and Doppler echocardiographic examinations performed. These patients were stratified a priori into four groups according to ejection fraction (dichotomized arbitrarily at 0.25) and deceleration time (dichotomized at 130 milliseconds, which is -2 SD from the mean normal for our laboratory).6 A random sample of 200 patients was chosen to obtain approximately equal samples in each. Patient medical records were screened, and only patients with the clinical diagnosis of idiopathic dilated cardiomyopathy were included in the study. Criteria for inclusion included an ejection fraction <0.50 and the absence of a clear etiology. Patients in whom a clear cause for cardiomyopathy was identified or suspected (for example, coronary artery disease, valvular heart disease, infiltrative processes) were excluded. Coronary angiography and endomyocardial biopsy were not considered mandatory for inclusion. Patients who had incomplete or technically inadequate two-dimensional or Doppler echocardiographic studies were excluded. In this manner, a cohort of 102 patients was identified.
Echocardiographic Examination
Comprehensive two-dimensional and Doppler echocardiographic examinations were performed in all patients, as described previously,78 with commercially available echocardiographic instruments. The left atrial dimension was measured in the parasternal long-axis view, and the right ventricular dimension was measured in the parasternal short-axis view. Multiple logistic regression analysis was used to determine independent correlates of symptom status. Results are reported as odds ratios associated with specific contrasts in predictor variables. Survival was estimated by the Kaplan-Meier product-limit method, with the follow-up period starting at the index echocardiogram, and group differences were assessed with the log rank test. Of particular interest was the stratified comparison based on ejection fraction and deceleration time. Univariate and multivariate Cox proportional hazards models were constructed to assess univariate as well as independent associations with survival. Results of these models were reported as hazard ratios associated with specific contrasts in the predictor variables.
Statistical significance was judged at the two-sided .05 level. With 102 patients and 35 fatal events occurring during followup, the study had 80% power to detect a standardized Cox regression coefficient of .45, equivalent to a 1 SD shift (decrease) in deceleration time being associated with a relative hazard of 1.57.
Results
Baseline Characteristics
The clinical characteristics of the cohort of 102 patients (65 men and 37 women; mean age, 61±+ 14 years), determined at the time of the index echocardiographic examination, are listed in Logistic regression analysis was performed to determine correlates of symptom status ( Because on inspection of the data (Fig 3) were the most powerful predictors; heart rate, NYHA functional class, stroke volume, and age were also significant in univariate analysis. Two variables of diastolic dysfunction, the mitral deceleration time and the E/A ratio, were correlated with long-term survival in univariate analysis.
Multivariate proportional hazards models were constructed, and the strongest model is depicted in Table 5 . Two recently published European series4,5 examined left ventricular diastolic filling variables among patients with dilated cardiomyopathy. As in the current study, restrictive filling was highly associated with severe symptoms. Unlike the current study, however, restrictive filling was the most powerful predictor of future cardiac events and mortality. Because all retrospective case control and cohort studies are unavoidably affected by selection and referral biases, many important differences in the patient populations studied are apparent. We used a stratified random sample for case selection in an attempt to ensure a broad range of deceleration times and ejection fractions, whereas the other studies used consecutive case series. Regional variability may have had a role in determining differences in patient cohorts; for example, in one study4 the mean age of the cohort was 39 years, significantly less than that in the current study. Significant variability in a priori selection criteria existed as well; for example, minimally symptomatic patients and those with atrial fibrillation or severe mitral regurgitation were excluded but those with ischemic cardiomyopathy were included in one study. 5 Important differences in construction of multivariable models also exist: in one study,4 neither fractional shortening nor ejection fraction were included in the multivariate analysis, and in another study,5 blood pressure was excluded. Thus, direct comparison of results is difficult.
Strengths and Limitations
All echocardiographic examinations were performed in an experienced laboratory and the data were reterm follow-up information, patients examined when Doppler interrogation became routine in our laboratory (1986) were included. However, our study was a retrospective cohort analysis and has the inherent limitations of this design. Whereas the extremely short deceleration times in the severely symptomatic group are consistent with a rapidly decreasing early diastolic filling gradient with increasing left ventricular diastolic pressure (rapid filling wave), we were unable to assess the independent effect of mitral regurgitation on the mitral flow velocity profile, in particular, the E velocity. It is possible that the observed higher peak E velocities in the severely symptomatic group were partly due to the higher prevalence of moderate or severe mitral regurgitation among this group.
In the early application of Doppler echocardiogra- 
